Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637959 · ClinicalTrials.gov registry record · NA
Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging
A NA study of Liver Fibrosis, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT03637959: Completed NA study of Liver Fibrosis, sponsored by Mayo Clinic.
NCT03637959 is a NA study of Liver Fibrosis that has completed, run by Mayo Clinic. The registered enrollment target is 270 participants, below the 349-participant average among 11 other Liver Fibrosis trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637959, a NA study of Liver Fibrosis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
The Researchers are trying to assess the effectiveness of a new ultrasound technique for non-invasive evaluation of liver fibrosis.
Primary Outcome
Liver stiffness measured by standard of care Magnetic Resonance Elastography reported in Kilopascals (kPa) (used as a benchmark reference in this study).
Conditions Studied
Interventions
- DEVICE Mechanical Vibrations with Ultrasound Shear Wave Imaging
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2017-01-26 |
| Est. Completion | 2020-11-04 |
| Phase | NA |
What the finished NCT03637959 record still lists
NCT03637959 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 349-participant average among 11 other Liver Fibrosis trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Liver Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Mechanical Vibrations with Ultrasound Shear Wave Imaging is the first listed.
NCT03637959 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03637959 about?
NCT03637959 is a clinical study titled "Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging". The Researchers are trying to assess the effectiveness of a new ultrasound technique for non-invasive evaluation of liver fibrosis.
What is the current status of trial NCT03637959?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2017-01-26. Estimated completion is 2020-11-04.
What conditions does trial NCT03637959 study?
This clinical trial studies the following conditions: Liver Fibrosis.
What interventions are being tested in trial NCT03637959?
The interventions under investigation include: Mechanical Vibrations with Ultrasound Shear Wave Imaging (DEVICE).
Who is sponsoring clinical trial NCT03637959?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03637959 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03637959's enrollment target sits among peer trials
270 4th of 11 higher than 8 of 11 other Liver Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
RECRUITING · Phase 1
-
Fibrosis Lessens After Metabolic Surgery
RECRUITING · Phase 4
-
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
RECRUITING · Phase 2
-
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
RECRUITING
-
Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI